{
  "ticker": "JNJ",
  "target_date": "2025-06-19",
  "actual_date": "2025-06-18",
  "collected_at": "2025-12-08T11:54:48.942418",
  "price": {
    "open": 150.5,
    "high": 150.58,
    "low": 148.67,
    "close": 148.68763732910156,
    "volume": 8325200,
    "change_1d_pct": -1.08,
    "change_7d_pct": -2.9,
    "change_30d_pct": -1.58
  },
  "technicals": {
    "rsi_14": 41.43,
    "sma_20": 151.92,
    "sma_50": 150.97,
    "macd": 0.199,
    "macd_signal": 0.448,
    "macd_histogram": -0.25,
    "bb_upper": 155.61,
    "bb_lower": 148.23,
    "price_vs_sma20_pct": -2.13,
    "price_vs_sma50_pct": -1.51,
    "volume_ratio": 1.15
  },
  "fundamentals": {
    "market_cap": 489086910464,
    "pe_ratio": 19.594595,
    "forward_pe": 19.150942,
    "price_to_book": 6.161411,
    "price_to_sales": 5.307566,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.31,
    "pct_from_52w_low": 44.3
  },
  "macro": {
    "spy": {
      "price": 594.03,
      "change_1d_pct": -0.02,
      "change_7d_pct": -0.94
    },
    "vix": {
      "level": 20.14,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.4
    },
    "dollar_index": {
      "level": 98.91
    },
    "gold": {
      "price": 3389.8
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Johnson & Johnson (NYSE:JNJ) Faces US$8 Million Verdict Over Talcum Powder Cancer Case",
      "source": "Yahoo",
      "datetime": 1750353944,
      "summary": "Johnson & Johnson (NYSE:JNJ) recently faced significant legal challenges resulting in an $8 million jury award related to its talcum powder products, which may have contributed to its 1% decline over the past month. Despite this legal development, the company remains active in its clinical trials, s",
      "url": "https://finnhub.io/api/news?id=66ae0ab25c13d4a93e5896cc44b877a92019c1501887eb0a64e03ec6df6b681d"
    },
    {
      "headline": "J&J MedTech introduces new plates for VOLT fracture management platform",
      "source": "Yahoo",
      "datetime": 1750351211,
      "summary": "Launched in 2024 with mini and small fragment plates, J&J MedTech\u2019s VOLT platform now features plates for wrist and proximal humerus fractures.",
      "url": "https://finnhub.io/api/news?id=6397e692530bde524bf6b6bcec0a830091ff0c1a6fd7ee63f3400b1cc90fadfc"
    },
    {
      "headline": "Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know",
      "source": "Yahoo",
      "datetime": 1750338005,
      "summary": "Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=3b3f513ee34c1b7ff62a4930302628d7ceadc6c7983cdae4ecb032929864b16b"
    },
    {
      "headline": "J&J Launches Volt Wrist And Proximal Humerus Plating Systems In US",
      "source": "Finnhub",
      "datetime": 1750335374,
      "summary": "Johnson & Johnson: * J&J: LAUNCHES VOLT WRIST AND PROXIMAL HUMERUS PLATINGSYSTEMSIN THE U.S.Source text:Further company coverage: ...",
      "url": "https://finnhub.io/api/news?id=57b8556caa66a45cf465eb83ab1cbe6998b2d491469610d895676191f6122f13"
    },
    {
      "headline": "Johnson & Johnson : Launches VOLT\u2122 Wrist and Proximal Humerus Plating Systems in the U.S.",
      "source": "Finnhub",
      "datetime": 1750330208,
      "summary": "Media Contact: Lindsey Diaz-MacInnis ldiazmac@its.jnj.com Abhi Basu abasu26@its.jnj.com Investor contact: Sandra Easton: seaston@its.jnj.com ...",
      "url": "https://finnhub.io/api/news?id=36da6b373d47fdb59517486d6292368c309c9a246a414e2d0df036e83d3e4f70"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-06-12",
      "description": "xslF345X05/wk-form4_1749760336.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000156/xslF345X05/wk-form4_1749760336.xml"
    },
    {
      "form": "4",
      "date": "2025-06-12",
      "description": "xslF345X05/wk-form4_1749760229.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000154/xslF345X05/wk-form4_1749760229.xml"
    },
    {
      "form": "8-K",
      "date": "2025-06-10",
      "description": "jnj-20250610.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000152/jnj-20250610.htm"
    },
    {
      "form": "13F-HR",
      "date": "2025-05-07",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000238/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-05-05",
      "description": "xslF345X05/wk-form4_1746479407.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000143/xslF345X05/wk-form4_1746479407.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}